Beaumont Financial Advisors LLC Has $1.60 Million Position in Azenta, Inc. (NASDAQ:AZTA)

Beaumont Financial Advisors LLC reduced its holdings in Azenta, Inc. (NASDAQ:AZTAFree Report) by 22.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 24,531 shares of the company’s stock after selling 7,000 shares during the quarter. Beaumont Financial Advisors LLC’s holdings in Azenta were worth $1,598,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. TFC Financial Management Inc. acquired a new position in Azenta in the third quarter valued at approximately $25,000. Headlands Technologies LLC acquired a new position in Azenta in the third quarter valued at approximately $33,000. State of Wyoming lifted its holdings in Azenta by 29.5% in the second quarter. State of Wyoming now owns 1,392 shares of the company’s stock valued at $65,000 after buying an additional 317 shares during the period. Neo Ivy Capital Management acquired a new stake in Azenta in the third quarter worth $73,000. Finally, Allworth Financial LP raised its holdings in Azenta by 273.1% in the fourth quarter. Allworth Financial LP now owns 1,634 shares of the company’s stock worth $106,000 after purchasing an additional 1,196 shares during the period. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Up 0.0 %

Shares of AZTA stock traded up $0.01 during trading hours on Friday, hitting $50.50. 193,103 shares of the company were exchanged, compared to its average volume of 424,806. The business has a 50 day moving average of $60.97 and a two-hundred day moving average of $58.91. Azenta, Inc. has a 52 week low of $36.01 and a 52 week high of $69.16.

Azenta (NASDAQ:AZTAGet Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. The company had revenue of $154.32 million during the quarter, compared to the consensus estimate of $151.86 million. As a group, equities research analysts predict that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on AZTA shares. Evercore ISI cut their target price on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a report on Thursday, April 4th. Stephens reiterated an “equal weight” rating and issued a $70.00 target price on shares of Azenta in a report on Thursday, February 8th. Needham & Company LLC reiterated a “buy” rating and issued a $75.00 target price on shares of Azenta in a report on Monday, April 8th. Jefferies Financial Group started coverage on shares of Azenta in a report on Thursday, April 4th. They issued a “hold” rating and a $64.00 target price on the stock. Finally, B. Riley increased their target price on shares of Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $69.60.

View Our Latest Analysis on AZTA

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.